Injecting unlicensed peptides: infection and sepsis risks
Last reviewed by retainfo editorial team. How we review content.
People often think of an online "research peptide" as being like a supplement: a grey-area product that might not work but probably will not hurt. An injectable is different in kind. It goes straight past every defence your body has, and nothing about it has been checked for sterility, contamination or strength. This page explains what that means, what infection looks like, and where to get help without being judged.
Why an injectable is not a supplement
If you swallow something contaminated, your stomach acid, gut lining and liver get a chance to deal with it, and you usually just feel unwell. An injection skips all of that. Whatever is in the liquid, including bacteria, bacterial toxins, solvents, the wrong drug or the right drug at the wrong strength, goes directly into your tissue and bloodstream.
That is why licensed injectable medicines are made in clean rooms, filtered, tested for sterility and endotoxin on every batch, and released only when the results pass.[8] The products sold online as retatrutide have been through none of that. They are made in warehouses and farm buildings, as the MHRA raids showed, and then sent through the post.[2]
Sterility and endotoxin
Two separate things can go wrong with a vial.
Live bacteria. If the product or the vial was not sterile, bacteria go into the injection site. That is where abscesses and cellulitis come from.
Endotoxin. Even if the bacteria are dead, fragments of their cell walls remain. These are called endotoxins. They cause fever, chills, low blood pressure and, in larger amounts, shock. Heat and filtering do not remove them, which is why licensed manufacturers test for them separately.
A 2024 study in the Journal of Medical Internet Research bought three semaglutide vials from online sellers and tested them. None contained live bacteria at the time of testing. All three contained endotoxin, at up to 8.95 endotoxin units per milligram. Purity ranged from 7.7% to 14.4% against a claimed 99%, and each vial held 29% to 39% more drug than its label said. The authors classed all three as substandard and falsified.[1]
That is three vials of a different drug, so it cannot tell you what is in any given retatrutide vial. It does show that "sterile" and "clean" are not the same thing, and that a vial can pass a sterility test and still carry a fever-causing contaminant. More on testing results at what is actually in the vials.
What an injection-site infection looks like
Cellulitis is an infection of the skin and the tissue under it. The area becomes painful, hot and swollen. On white skin it is usually red; on brown or black skin the colour change can be harder to see. You may feel unwell, with flu-like symptoms and swollen glands. The NHS advises an urgent GP appointment or NHS 111 if your skin is painful, hot and swollen, because early antibiotics stop it becoming serious.[9]
An abscess is a painful lump containing pus. It usually feels warm, is often round, and the middle may feel soft. Pus may leak out and you may have a high temperature. Some abscesses need to be drained by a doctor.[10]
A little redness for a day at an injection site is common with any injection, including licensed ones. Spreading redness, heat, increasing pain, a lump filling with pus, or feeling unwell with it, is not normal and needs to be seen.
Sepsis
Sepsis is the body's extreme reaction to an infection. It can start from a skin infection and develops over a few hours. Untreated, it can become septic shock, which can be fatal. The NHS lists these symptoms in adults: confusion or slurred speech; uncontrollable shivering; muscle pain; difficulty breathing; blue, pale, grey or blotchy skin, lips or tongue; and a rash that does not fade when a glass is pressed on it. Anyone with these needs 999 or A&E.[3]
Blood-borne viruses and shared equipment
This is a general harm-reduction fact that applies to any injecting: sharing needles, syringes or any other equipment can pass hepatitis B, hepatitis C and HIV from one person to another.[4][11][5] "Equipment" is broader than the needle. The NHS lists syringes, spoons, filters and swabs as things never to share, because tiny amounts of blood can transfer on any of them.[4][5]
Two situations make this relevant to weight-loss products specifically:
- Group vials. A multi-dose vial that more than one person draws from is shared equipment, even if each person uses their own needle. Once a needle has been in a vial, whatever was on it is in the liquid.
- Pens that have been used. A pre-filled pen from an unknown source may already have been used, refilled or handled by someone else. The counterfeit pens page explains how empty pens were being filled by hand in the UK.
Hepatitis C is curable and hepatitis B is preventable by vaccine, but both can damage the liver silently for years. If you have ever shared equipment, the NHS advises getting tested. Testing is free and confidential through your GP, a sexual health clinic or a local drug service.[4][5]
Reusing your own needles and vials
Reusing your own equipment does not risk passing on a virus, but it does raise the infection risk from the first section. A needle that has been used is blunt, has skin bacteria on it, and has been exposed to the air. A vial that has been punctured is no longer sealed; every entry is a chance for bacteria to get in, and the liquid then sits at room temperature until the next time.
Storage and temperature
Peptides are fragile molecules. Licensed peptide injectables carry strict storage conditions, are kept refrigerated through the supply chain, and have a stated life once opened, because heat and time break the molecule down.[8] A vial that has been posted in a padded envelope, sat in a depot, and then lived in a bathroom cabinet has had none of that control. Degraded peptide is less active, and its breakdown products have not been studied in people. This is one of the reasons why "it did nothing" and "it hit far harder than expected" are both common in community reports. This site does not give storage instructions, because there is no way to make an unregulated product safe by storing it well.
Beyond infection
Contamination can do more than infect a site. In Victoria, Australia, people using products labelled retatrutide developed acute liver injury, and doctors suspect contaminants rather than the drug itself.[12] The liver-injury cluster page has the detail. Injection is also the route by which a mislabelled product gets into you at full strength, with no chance to stop once it is in.
Help without judgement
Harm-reduction services exist in every part of the UK and they will help you whatever you are injecting. The NHS says that if you need help with a drug problem you are entitled to treatment in the same way as anyone else with a health problem, and that your GP will usually refer you to the local drug service. You can also contact a local drug service directly, or call the Frank helpline on 0300 123 6600.[6] Local drug services offer testing and treatment for hepatitis and HIV as part of reducing the risks of injecting.[6]
Many community pharmacies run needle and syringe exchange schemes as part of their substance-misuse service. Ask a pharmacist what they offer; they will not lecture you.[7] If you are not sure where to start, ask your pharmacist or your local drug and alcohol service.
References
- Ashraf AR, Mackey TK, Vida RG, et al. Multifactor Quality and Safety Analysis of Semaglutide Products Sold by Online Sellers Without a Prescription. Journal of Medical Internet Research 2024 (doi:10.2196/65440), 1 November 2024. Primary source
- MHRA smashes major illicit weight loss medicine production facility in record seizure. GOV.UK / MHRA press release, 24 October 2025. Primary source
- Sepsis. NHS, 1 January 2026. NHS / NICE guidance
- Hepatitis C. NHS, 1 January 2026. NHS / NICE guidance
- HIV and AIDS. NHS, 1 January 2026. NHS / NICE guidance
- Drug addiction: getting help. NHS, 1 January 2026. NHS / NICE guidance
- How your pharmacy can help. NHS, 1 January 2026. NHS / NICE guidance
- Wegovy (semaglutide) Summary of Product Characteristics. electronic medicines compendium (emc), 1 January 2026. Primary source
- Cellulitis. NHS, 1 January 2026. NHS / NICE guidance
- Skin abscess. NHS, 1 January 2026. NHS / NICE guidance
- Hepatitis B. NHS, 1 January 2026. NHS / NICE guidance
- Melbourne woman suffers acute liver failure after using knock-off drug. ABC News (Australia), 20 June 2026. Secondary source